These compounds may interact with:
Fructose-1,6-bisphosphatase 1
Potentially involved in: fructose-1,6-bisphosphatase deficiency; lactic acidosis; apnea; colonic neoplasms; comatose; dyspnea; epilepsy; fever; fructose-1,6-diphosphatase deficiency; hepatomegaly; hyperventilation; hypoglycemia; ketosis; lethargy; muscle hypotonia; parkinson disease; schizophrenia; seizures; stomach neoplasms; tachycardia
Disease data sourced from Pharos.